Dingell Hearings On Science Fraud: More Overkill Than Oversight

As chairman of the House Energy and Commerce Committee, which oversees the NIH, and its subcommittee on oversight and investigations, Rep. John Dingell (D-Mich.) has been investigating scientific fraud for over a year. No one questions the subcommittee's legitimate role of investigating fraud and ensuring that public funds are wisely spent. But many object to Dingell's unfair conduct and heavy-handed tactics. The subcommittee seems to have overstepped its mission as a watchdog of public funds. T

Written byEugene Garfield
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The subcommittee seems to have overstepped its mission as a watchdog of public funds. The recent hearings, held in May, leave the impression that Dingell is presiding over a kangaroo court, not a congressional inquiry.

The Dingell subcommittee has focused specifically on a disputed 1986 paper published in Cell (vol. 45, pages 247-259) and coauthored by David Baltimore, a Nobel laureate. Two university reviews and an official NIH investigation of the paper agree that certain data were misinterpreted but not intentionally misrepresented. All agree that the paper is an example of scientific error, not fraud.

This important distinction is lost on Dingell. At the May hearings, Dingell stressed his interest in preventing the waste of taxpayers' money on "faked" research. He has implied that a composite autoradiograph in the paper was a "fabrication," despite the authors' explanation that composites are commonly used.

Dingell's obvious bias has alarmed scientists and his ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery